Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Long‐term safety and activity of NY-ESO‐1 SPEAR T cells after autologous stem cell transplant for myeloma

Blood Adv (2019) 3 (13): 2022–2034.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals